Hester Bios

{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,649.65",
    "chg": 11.45,
    "chgp": "0.7%",
    "dir": 1,
    "prev_price": "1,638.20",
    "mcapval": "1,406.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "3.73 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-3973001",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_mojoScore_3973001.png",
        "date": "2026-05-03 10:10:02",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-valuation-shifts-signal-heightened-price-risk-amid-sector-comparisons-3963490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_valuationdot_3963490.png",
        "date": "2026-04-27 08:00:18",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift markedly, moving from expensive to very expensive territory. Despite a modest day gain of 1.27%, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios raise questions about its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Hester Biosciences Gains 0.35%: 3 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-gains-035-3-key-factors-driving-the-weeks-mixed-momentum-3962957",
        "imagepath": "",
        "date": "2026-04-26 09:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> Stock opens at Rs.1,477.25, down 1.04% amid weak market sentiment</p>\n                    <p><strong>21 Apr:</strong> Technical momentum shifts amid bearish signals; valuation shifts to “expensive” rating</p>\n                    <p><strong>22 Apr:</strong> Technical momentum shows mild improvement but remains cautious</p>\n                    <p><strong>24 Apr:</strong> Stock closes the week at Rs.1,498.00, up 1.27% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,492.80</div></div>\n                    <div class=\"stat-item\"><..."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-3956735",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_mojoScore_3956735.png",
        "date": "2026-04-22 10:10:03",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3956698",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_technicaldot_3956698.png",
        "date": "2026-04-22 08:01:07",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day gain of 0.25%, the stock’s technical indicators present a complex picture, with weekly signals showing mild bullish tendencies contrasting with monthly bearish trends. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity amid mixed signals."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-bearish-signals-3954920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_technicaldot_3954920.png",
        "date": "2026-04-21 08:01:42",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bearish to a more pronounced bearish stance. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum and trend indicators signal weakening price strength."
      },
      {
        "title": "Hester Biosciences Ltd: Valuation Shifts Signal Price Attractiveness Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-valuation-shifts-signal-price-attractiveness-amid-sector-challenges-3954800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_valuationdot_3954800.png",
        "date": "2026-04-21 08:00:21",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions of the stock’s price attractiveness amid fluctuating financial metrics and sector comparisons."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-3942457",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_mojoScore_3942457.png",
        "date": "2026-04-11 10:10:25",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Markets Rally, But Hester Biosciences Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-stock-hits-52-week-low-at-rs125095-3928437",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_priceRelatedfactors_3928437.png",
        "date": "2026-04-01 09:53:00",
        "description": "Despite a broadly positive market environment, Hester Biosciences Ltd has fallen to a fresh 52-week low of Rs 1,250.95 on 1 Apr 2026, marking a 10.27% decline over the past year and underperforming the Sensex by a wide margin."
      }
    ],
    "total": 5454,
    "sid": "324228",
    "stock_news_url": "https://www.marketsmojo.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Financial Results And Dividend",
      "datetime": "08-May-2026",
      "details": "Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended 31 March 2026 and to consider the declaration of dividend if any on the equity shares of the Company for the financial year 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "Confirmation Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended 31 March 2026",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "03-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Hester Biosciences Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L99999GJ1987PLC022333</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>12.78</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BBB+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: VINODKUMAR MALI <br/> Designation: Company Secretary and Compliance officer <br/> EmailId: vinod.mali@hester.in</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Ashish Desai <br/> Designation: Chief Financial Officer <br/> EmailId: cs@hester.in</div> </div> <div> <br/> Date: 03/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>70%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Hester Biosciences Ltd is Rated Sell

2026-05-03 10:10:02

Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Hester Biosciences Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons

2026-04-27 08:00:18

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift markedly, moving from expensive to very expensive territory. Despite a modest day gain of 1.27%, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios raise questions about its price attractiveness relative to peers and historical benchmarks.

Read full news article

Hester Biosciences Gains 0.35%: 3 Key Factors Driving the Week’s Mixed Momentum

2026-04-26 09:00:04

Key Events This Week

20 Apr: Stock opens at Rs.1,477.25, down 1.04% amid weak market sentiment

21 Apr: Technical momentum shifts amid bearish signals; valuation shifts to “expensive” rating

22 Apr: Technical momentum shows mild improvement but remains cautious

24 Apr: Stock closes the week at Rs.1,498.00, up 1.27% on the day

Week Open

Rs.1,492.80

<...

Read full news article

Hester Biosciences Ltd is Rated Sell

2026-04-22 10:10:03

Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-22 08:01:07

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day gain of 0.25%, the stock’s technical indicators present a complex picture, with weekly signals showing mild bullish tendencies contrasting with monthly bearish trends. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity amid mixed signals.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Amid Bearish Signals

2026-04-21 08:01:42

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bearish to a more pronounced bearish stance. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum and trend indicators signal weakening price strength.

Read full news article

Hester Biosciences Ltd: Valuation Shifts Signal Price Attractiveness Amid Sector Challenges

2026-04-21 08:00:21

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions of the stock’s price attractiveness amid fluctuating financial metrics and sector comparisons.

Read full news article

Hester Biosciences Ltd is Rated Sell

2026-04-11 10:10:25

Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Markets Rally, But Hester Biosciences Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-01 09:53:00

Despite a broadly positive market environment, Hester Biosciences Ltd has fallen to a fresh 52-week low of Rs 1,250.95 on 1 Apr 2026, marking a 10.27% decline over the past year and underperforming the Sensex by a wide margin.

Read full news article

View All News